MDL-28815

N/A

Report date: 2023/01/14 16:58:30

Base Information

Drug NameMDL-28815

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCholesterol synthesis inhibitors

TargetsNot applicable

Therapy Area/IndicationsHypercholesterolemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis

Active IndicationsN/A

Inactive IndicationsHypercholesterolemia

ATC CodeN/A